Hsi-Hsien Hsu Selected Research

Hsi-Hsien Hsu Research Topics

Disease

27	Neoplasms (Cancer) 10/2019 - 04/2010
14	Neoplasm Metastasis (Metastasis) 11/2018 - 09/2006
12	Colorectal Neoplasms (Colorectal Cancer) 10/2019 - 04/2006
12	Colonic Neoplasms (Colon Cancer) 01/2018 - 04/2006
9	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 04/2010
5	Mouth Neoplasms (Oral Cancer) 01/2019 - 01/2013
4	Carcinogenesis 06/2018 - 02/2012
4	Hypoxia (Hypoxemia) 01/2018 - 10/2008
4	Hypertrophy 06/2008 - 03/2006
3	Fibrosis (Cirrhosis) 03/2017 - 10/2008
3	Carcinoma (Carcinomatosis) 05/2012 - 04/2006
2	Rectal Neoplasms (Rectal Cancer) 08/2022 - 09/2006
2	Myocardial Infarction 11/2017 - 06/2017
2	Type 2 Diabetes Mellitus (MODY) 11/2017 - 04/2006
2	Heart Failure 06/2017 - 03/2017
2	Liver Neoplasms (Liver Cancer) 02/2017 - 01/2013
2	Cardiomegaly (Heart Hypertrophy) 06/2008 - 01/2005
2	Adenoma (Adenomas) 09/2006 - 04/2006
2	Hypertension (High Blood Pressure) 08/2006 - 01/2005
1	Osteosarcoma (Osteogenic Sarcoma) 02/2018
1	Ischemic Stroke 11/2017
1	Arteriosclerosis 11/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2017
1	Hyperlipidemias (Hyperlipidemia) 11/2017
1	Obesity 11/2017
1	Atherosclerosis 11/2017
1	Aneurysm (Aneurysms) 06/2017
1	Squamous Cell Carcinoma of Head and Neck 12/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2005
7	Matrix Metalloproteinases (MMPs)IBA 08/2017 - 08/2011
6	CateninsIBA 02/2017 - 01/2013
5	Dinoprostone (PGE2)FDA Link 05/2017 - 09/2010
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2019 - 01/2018
4	Arecoline (Arecolin)IBA 01/2019 - 12/2016
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 07/2014
4	thymoquinoneIBA 02/2017 - 01/2013
3	fisetinIBA 11/2020 - 01/2018
3	Histone Deacetylase InhibitorsIBA 11/2020 - 01/2014
3	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 09/2006
3	Leucovorin (Folinic Acid)FDA Link 01/2018 - 09/2006
3	p38 Mitogen-Activated Protein KinasesIBA 08/2017 - 09/2010
3	ProstaglandinsIBA 05/2017 - 09/2010
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2014 - 08/2011
3	apicidinIBA 01/2014 - 01/2013
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2013 - 08/2011
2	Protein Phosphatase 1IBA 11/2020 - 06/2019
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 06/2008
2	taiwanin EIBA 01/2019 - 08/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2018 - 07/2014
2	Protein Isoforms (Isoforms)IBA 06/2018 - 02/2012
2	GelsolinIBA 01/2018 - 01/2016
2	Messenger RNA (mRNA)IBA 07/2017 - 01/2013
2	Estrogens (Estrogen)FDA Link 02/2017 - 09/2006
2	taiwanin CIBA 01/2017 - 01/2017
2	Estradiol (Delestrogen)FDA LinkGeneric 11/2014 - 04/2006
2	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2012 - 08/2011
2	Metalloproteases (Metalloproteinases)IBA 11/2012 - 08/2011
2	Protein Kinase CIBA 02/2012 - 04/2010
2	SB 203580IBA 08/2011 - 09/2010
2	U 0126 (UO 126)IBA 08/2011 - 09/2010
2	pyrazolanthroneIBA 08/2011 - 09/2010
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 08/2011 - 09/2010
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 04/2010 - 04/2006
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2009 - 08/2006
2	IronIBA 02/2009 - 08/2006
2	LipidsIBA 02/2009 - 04/2006
2	CalcineurinIBA 06/2008 - 03/2006
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	FlavonoidsIBA 06/2019
1	Cell Cycle ProteinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	lupeolIBA 05/2018
1	PPAR alphaIBA 02/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	PlatinumIBA 01/2018
1	oxidized low density lipoproteinIBA 11/2017
1	Blood Proteins (Serum Proteins)IBA 11/2017
1	CholesterolIBA 11/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2017
1	LDL CholesterolIBA 11/2017
1	Triglycerides (Triacylglycerol)IBA 11/2017
1	Phytoestrogens (Phytoestrogen)IBA 08/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2017
1	Protective AgentsIBA 03/2017
1	PhytochemicalsIBA 02/2017
1	CarcinogensIBA 01/2017
1	helioxanthinIBA 12/2016
1	Cyclin-Dependent Kinase Inhibitor p27IBA 12/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2016
1	SilymarinIBA 05/2016
1	Caspase 8 (Caspase-8)IBA 05/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	lauric acid (dodecanoic acid)IBA 01/2016

Therapy/Procedure

12	Therapeutics 06/2019 - 04/2006
4	Drug Therapy (Chemotherapy) 01/2018 - 02/2012
1	Neoadjuvant Therapy 08/2022
1	Injections 05/2018